The study investigates how changes in alkaline phosphatase (ALP) and γ-glutamyltransferase (GGT) levels affect the prognosis of patients with primary liver cancer (PLC) after they undergo radiofrequency ablation (RFA).
Data was collected from 165 patients treated with RFA between 2018 and 2023, utilizing statistical methods like chi-square tests and Cox regression to analyze survival outcomes.
Results indicated that both normal ALP and GGT levels correlated with significantly better survival rates compared to abnormal levels, with ALP and GGT identified as key independent prognostic factors for overall survival in PLC patients post-treatment.